A phase II trial of etoposide, folinic acid, fluorouracil and epirubicin in advanced pancreatic carcinoma

Clinica Terapeutica

Volumn 149, Issue 5, 1998, Pages 351-355

  Maiello, Evaristo ^b   Gebbia, V ^c   Giuliani, F ^c   Testa, A ^c   Giotta, F ^c   Gebbia, N ^a   Colucci, G ^c  

^a UNIVERSITY OF PALERMO   (Italy)

^b NATIONAL CANCER INSTITUTE GIOVANNI PAOLO II   (Italy)

^c NONE

Author keywords

5 fluorouracil; Epirubicin; Pancreatic cancer

Indexed keywords

ANTINEOPLASTIC AGENT; EPIRUBICIN; ETOPOSIDE; FLUOROURACIL; FOLINIC ACID;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CLINICAL ARTICLE; CLINICAL TRIAL; DIARRHEA; DRUG INDUCED DISEASE; FEMALE; HUMAN; LEUKOPENIA; MALE; MUCOSA INFLAMMATION; PANCREAS CARCINOMA; PHASE 2 CLINICAL TRIAL; TREATMENT OUTCOME;

AGED; ANTIBIOTICS, ANTINEOPLASTIC; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DRUG RESISTANCE, NEOPLASM; EPIRUBICIN; ETOPOSIDE; FEMALE; FLUOROURACIL; HUMANS; LEUCOVORIN; MALE; NEOPLASM STAGING; PANCREATIC NEOPLASMS;

EID: 0032444972     PISSN: 00099074     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Schnall SF, Macdonald JS: Chemotherapy of adenocarcinoma of the pancreas. Semin Oncol 23: 220-228, 1996
2. Ahlgren JD: Pancreatic cancer: chemotherapy of advanced disease. In: Ahlgren JD and Macdonald JS (eds): Gastrointestinal Oncology, Philadelphia, JB Lippincott Company, 1992, pp 227-235
3. Bertino JR, Mini E: Does modulation of 5-fluorouracil by metabolites or antimetabolites work in clinic? In Harrap KR, Connors TA (eds): New avenues in developmental cancer chemotherapy, Orlando, Academic Press 1987, pp 163-184
4. Osswald H, Kung W: Therapeutic synergism of eloposide and 5-fluorouracil combined sequentially in advanced leukemia. J Cancer Res Clin Oncol 113:53, 1987
5. Wilke H, Preusser P, Fink U, et al.: High dose folinic acid/etoposide/5-fluorouracil in advanced gastric cancer.: A phase II study in elderly patients or patients with cardiac risk. Invest New Drugs 29:83-84, 1990
6. Di Bartolomeo M, Bajetta E, de Braud F, et al.: Phase II study of the etoposide, leucovorin and fluorouracil combination for patients with advanced gastric cancer unsuitable for aggressive chemotherapy. Oncology 52: 41-44, 1995
7. Modiano M, Taylor C, Brooks R, et al.: Etoposide (E), Leucovorin (L), 5-fluorouracil (F), and interferon-α2a (I) (ELFI) is an active treatment for high-risk or advanced pancreatic or gastric adenocarcinoma. Proc Am Soc Clin Oncol 12:203, 1993
8. Colucci G, Giuliani F, Gebbia V, et al.: Epirubicin, folinic acid, fluorouracil, and etoposide in the treatment of advanced gastric cancer: a phase II study of the Southern Italy Oncology Group (GOIM). Am J Clin Oncol, in press
9. Miller AB, Hoogstraten B, Staquel M, et al.: Reporting results of cancer treatment. Cancer 59: 207-241, 1981
10. Ahlgren JD: Chemotherapy for pancreatic carcinoma. Cancer 78 (suppl): 654-663, 1996
11. Moran RG, Keyomarsi K: Biochemical rationale for the synergism of 5-Fluorouracil and folinic acid. NCI Monogr 5:159-163, 1987
12. Rustum YM, Trave F, Zakrzewski SF, et al.: Biochemical and pharmacologic basis for potentiation of fluorouracil action by leucovorin. NCI Monogr 5:165-170, 1987
13. De Caprio JA, Mayer RJ, Gonin R, et al.: Fluorouracil and high-dose leucovorin in previously untreated patients with advanced adenocarcinomas of the pancreas: results of a phase II trial. J Clin Oncol 9:2128-2133, 1991
14. Crown J, Casper ES, Botet J, et al.: Lack of efficacy of high-dose leucovorin and fluorouracil in patients with advanced pancreatic adenocarcinoma. J Clin Oncol 9:1682-1686, 1991
15. Pazdur R, Ajani JJ, Abbruzzese JL, et al.: Phase II evaluation of fluorouracil and α-2a-interferon in previously untreated patients with pancreatic adenocarcinoma. Cancer 70:2073-2076, 1992
16. Scheithauer W, Pfeffel F, Kornek G, et al. A phase II trial of fluorouracil, leucovorin and recombinant alpha-2b-interferon in advanced adenocarcinoma of the pancreas. Cancer 70:1864-1866, 1992
17. Rosvold E, Schilder RJ, Walczak J: Phase II trial of PALA in combination with 5-fluorouracil in advanced pancreatic cancer. Cancer Chemother Pharmacol 29:305-308, 1992
18. Gebbia V, Maiello E, Testa A, et al.: Treatment of advanced adenocarcinomas of the exocrine pancreas and the gallbladder with 5-fluorouracil, high dose levofolinic acid and oral hydroxyurea on a weekly schedule. Results od a multicenter study of the Southern Italy Oncology Group (G.O.I.M.). Cancer 78:1300-1307, 1996
19. Bitran JD, Desser RK, Kozloff MF, et al.: Treatment of metastatic pancreatic and gastric adenocarcinoma with 5-fluorouracil, adriamycin and mitomycin C (FAM). Cancer Treat Rep 63:2049-2051, 1979
20. Smith FP, Hoth DF, Levin B, et al.: 5-fluorouracil, adriamycin, and mitomycin C (FAM) chemotherapy for advanced adenocarcinoma of the pancreas. Cancer 46:2014-2018, 1980
21. Wiggans RG, Wooley PV, MacDonald JS, et al.: Phase II trial of streptozotocin, mitomycin C, and 5-fluorouracil (SMF) in the treatment of advanced pancreatic cancer. Cancer 44:387-391, 1978
22. Bukowky RM, Abderhalde RI, Hewlett JS: Phase II trial of streptozotocin, mitomycin C, and 5-fluorouracil in adenocarcinoma of the pancreas. Cancer Clin Trials 3:321-324, 1980
23. Bukowsky RM, Balcerzak SP, O'Bryan RM, et al.: Randomized trial of 5-fluorouracil and mitomycin C with or without streptozotocin for advanced pancreatic cancer. Cancer 52:1577-1582, 1983.
24. Cullinan SA, Moertel CG, Fleming TR, et al.: A comparison of three chemotherapeutic regimens in the treatment of advanced pancreatic and gastric adenocarcinoma: fluorouracil versus fluorouracil and doxorubicin versu fluorouracil, doxorubicin, and mitomycin C. JAMA 253:2061-2067, 1985.
25. Gastrointestinal Tumor Study Group: Phase II studies of drug combinations in advanced pancreatic carcinoma: fluorouracil plus doxorubicin plus mitomycin C and two regimens of streptozotocin plus mitomycin C plus fluorouracil. J Clin Oncol 4:1794-1798, 1986
26. Mallison CN, Rake MO, Cocking JB: Chemotherapy in pancreatic cancer: results of a controlled, prospective, randomized multicenter trial. BMJ 281: 1589-1591, 1980
27. Cullinan S, Moertel CG, Wieand HS, et al.: A phase III trial on the therapy of advanced pancreatic carcinoma. Cancer 65: 2207-2212, 1990
28. Glimelius B, Hoffman K, Sjoden PO: Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer. Ann Oncol 7:593-600, 1996
29. Burris III HA, Moore MJ, Andersen J, et al.: Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol 15:2403-2413, 1997